联合CT人体成分分析与预后炎症评分的列线图:预测晚期上皮性卵巢癌患者生存
回顾性纳入57例接受初次减瘤术及辅助铂类化疗的晚期上皮性卵巢癌患者,利用治疗前后CT测量人体成分变化并联合预后炎症评分构建列线图。多因素分析显示VFA增加、PMA减少、BMD减少及PIS为总生存独立危险因素,联合模型AUC达0.890,列线图C-index为0.779。
要点
- 治疗前后CT可量化皮下/内脏脂肪、椎旁肌面积与密度及骨密度变化
- VFA增加、PMA减少、BMD减少及PIS是总生存独立危险因素
- 联合人体成分变化与PIS的列线图对生存预测具有较好区分度
核心结论
- 基于CT的人体成分分析与PIS均与接受PDS及辅助铂类化疗的AEOC患者较差OS相关,联合BCC与PIS的预后列线图在治疗期间预测生存可靠。
研究设计与样本
- 回顾性纳入2012至2016年间57例AEOC患者,采用治疗前后两组CT图像分析人体成分生物标志物,测量SAT、VAT、PMA、SMD及BMD,并结合PIS构建列线图。
关键影像表现/征象
- 治疗前后CT图像用于测量皮下脂肪组织、内脏脂肪组织、椎旁骨骼肌横截面积、骨骼肌密度及骨密度。
诊断标准与关键数值
- 多因素分析中VFA增加、PMA减少、BMD减少及PIS为OS独立危险因素(HR分别为3.7、3.0、2.8、1.9,均p<0.05)。
- ROC曲线显示联合BCC与PIS的预后模型预测性能最高(AUC=0.890)。
- 预后列线图的C-index为0.779(95%CI 0.673-0.886)。
- 决策曲线分析显示预后列线图具有良好区分性能。
临床应用与阅片要点
- 作者认为联合BCC与PIS的预后列线图在AEOC患者治疗期间预测生存可靠。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the value of body composition changes measured by quantitative computer tomography (QCT) in evaluating the prognosis of advanced epithelial ovarian cancer (AEOC) patients who underwent primary debulking surgery (PDS) and adjuvant platinum-based chemotherapy, and constructed a nomogram model for predicting survival in combination with prognostic inflammation score (PIS).
METHOD: Fifty-seven patients with AEOC between 2012 and 2016 were retrospectively enrolled. Pre- and post-treatment CT images were used to analyze the body composition biomarkers. The subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), cross-sectional area of paraspinal skeletal muscle area (PMA), skeletal muscle density (SMD), body mineral density (BMD) were measured from two sets of CT images.
RESULTS: In multivariate analyses, VFA gain, PMA loss, BMD loss, and PIS were independent risk factors of overall survival (OS) (HR = 3.7, 3.0, 2.8, 1.9, respectively, all p < 0.05). Receiver operating characteristic (ROC) curves showed that the prognostic model combining body composition changes (BCC) and PIS had the highest predictive performance (area under the curve = 0.890). The concordance index (C-index) of the prognostic nomogram was 0.779 (95% CI, 0.673-0.886). Decision curve analysis (DCA) demonstrated the prognostic nomogram had a great distinguishing performance.
CONCLUSION: CT-based body composition analyses and PIS were associated with poor OS for AEOC patients who underwent PDS and adjuvant platinum-based chemotherapy. The prognostic nomogram with a combination of BCC and PIS was dependable in predicting survival for AEOC patients during treatment.
引用
- Wang, Zhang, Cao, et al. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients. Acad Radiol. 2021. PMID: 34955366. doi:10.1016/j.acra.2021.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。